Dear Clinical Team, We Have Just Two Words For You: Thank You.

When we look back at the key people that kept the world turning during these past difficult times, it’s a must that we pay our thanks to those behind the scenes who continued in their quests to enable drug development and to safely and accurately help bring drugs to market in the quickest possible way.

Displaying true professionalism day in and day out, the teams leading clinical trials here at QUINTA-ANALYTICA are an integral part of the pharma industry and have pushed harder than ever these past two years, adapting quickly to a constantly changing situation in order to keep volunteers safe and well cared for, and ensuring that trials continued operating for the advancement of new medicines.

Times may have been tough, but where there’s a will, there’s a way and the clinical team certainly epitomize this. So thank you, from all at Quinta!

To learn more about Quintas’ A-Z of services including more about the trials conducted in their own in-house facility get in touch with us today.

Additional News

  • 9 July 2025

    HER-096: A possible breakthrough in Parkinson’s disease treatment

    This testimonial highlights our collaboration with Herantis Pharma on the analytical development and nonclinical support for HER-096, a promising candidate in the fight against Parkinson’s disease.

  • 9 June 2025

    Ensuring Success in Buccal Film Development: The Midazolam Film Case Study

    Fast, Simple, Effective: Unlocking the Potential of Midazolam Films

  • 15 May 2025

    From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar.